ATE386729T1 - Cyclothiocarbamatderivate als progesteron- rezeptormodulatoren - Google Patents

Cyclothiocarbamatderivate als progesteron- rezeptormodulatoren

Info

Publication number
ATE386729T1
ATE386729T1 AT00930266T AT00930266T ATE386729T1 AT E386729 T1 ATE386729 T1 AT E386729T1 AT 00930266 T AT00930266 T AT 00930266T AT 00930266 T AT00930266 T AT 00930266T AT E386729 T1 ATE386729 T1 AT E386729T1
Authority
AT
Austria
Prior art keywords
alkyl
optionally substituted
aryl
ring
groups
Prior art date
Application number
AT00930266T
Other languages
English (en)
Inventor
Puwen Zhang
Andrew Fensome
Eugene Terefenko
Lin Zhi
Todd Jones
Mark Collins
Christopher Tegley
Jay Wrobel
James Edwards
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,354 external-priority patent/US6436929B1/en
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of ATE386729T1 publication Critical patent/ATE386729T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Detergent Compositions (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00930266T 1999-05-04 2000-05-01 Cyclothiocarbamatderivate als progesteron- rezeptormodulatoren ATE386729T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18301399P 1999-05-04 1999-05-04
US09/552,354 US6436929B1 (en) 1999-05-04 2000-04-19 Cyclothiocarbamate derivatives as progesterone receptor modulators

Publications (1)

Publication Number Publication Date
ATE386729T1 true ATE386729T1 (de) 2008-03-15

Family

ID=26878649

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00930266T ATE386729T1 (de) 1999-05-04 2000-05-01 Cyclothiocarbamatderivate als progesteron- rezeptormodulatoren

Country Status (24)

Country Link
EP (1) EP1175411B1 (de)
JP (2) JP4958338B2 (de)
KR (1) KR100732692B1 (de)
CN (1) CN1131856C (de)
AT (1) ATE386729T1 (de)
AU (1) AU766801B2 (de)
BG (1) BG65277B1 (de)
BR (1) BR0010214A (de)
CA (1) CA2371712C (de)
CZ (1) CZ20013952A3 (de)
DE (1) DE60038108T2 (de)
DK (1) DK1175411T3 (de)
EA (1) EA004511B1 (de)
ES (1) ES2301482T3 (de)
GE (1) GEP20043181B (de)
HU (1) HUP0203332A3 (de)
IL (1) IL146298A0 (de)
MX (1) MXPA01011287A (de)
NO (1) NO321370B1 (de)
NZ (1) NZ515353A (de)
PL (1) PL351083A1 (de)
SG (1) SG120970A1 (de)
SK (1) SK15922001A3 (de)
TR (1) TR200103285T2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407101B1 (en) * 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
DE60038108T2 (de) * 1999-05-04 2009-02-12 Wyeth Cyclothiocarbamatderivate als progesteron-rezeptormodulatoren
CN1938298B (zh) * 2004-04-08 2013-02-06 惠氏公司 减少硫代酰胺杂质的方法
CA2561014C (en) * 2004-04-08 2013-09-10 Wyeth Thioamide derivatives as progesterone receptor modulators
AU2005237520B2 (en) 2004-04-27 2012-01-19 Wyeth Purification of progesterone receptor modulators
PL1756095T3 (pl) * 2004-04-27 2008-10-31 Wyeth Corp Cyjanopirole zawierające cykliczne karbaminianowe i tiokarbaminianowe biaryle oraz sposoby ich wytwarzania
BRPI0512991A (pt) * 2004-07-07 2008-04-22 Wyeth Corp uso de uma progestina, kit farmaceuticamente útil adaptado para a administração oral diária, e, método de contracepção em uma fêmea em idade de parto
US7569679B2 (en) * 2004-08-13 2009-08-04 Wyeth Tanaproget derivatives, metabolites, and uses thereof
DE602006013114D1 (de) 2005-04-28 2010-05-06 Wyeth Corp Mikronisiertes tanaproget und zusammensetzungen damit
GT200600173A (es) * 2005-04-28 2006-11-22 Forma purificada de tranaproget
BRPI0610438A2 (pt) * 2005-04-28 2012-10-23 Wyeth Corp composição farmacêutica, cápsula, conjunto farmacêutico, e, processo para preparar uma composição
TW200716129A (en) * 2005-04-28 2007-05-01 Wyeth Corp Micronized tanaproget, compositions, and methods of preparing the same
BRPI0610433A2 (pt) * 2005-04-28 2010-11-23 Wyeth Corp forma polimórfica ii de tanaproget, processos para preparar a mesma, e para preparar forma micronizada de um composto, composição farmacêutica, método de preparação de uma composição farmacêutica, e, uso da forma polimórfica ii de tanaproget ou da forma micronizada
HN2006020928A (es) * 2005-06-09 2011-02-16 Wyeth Corp "composiciones de tanaproget que contienen etinil estradiol"

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0510235A1 (de) * 1991-04-26 1992-10-28 Dong-A Pharm. Co., Ltd. Benzoxazin- oder Benzothiazinderivate und Verfahren zu deren Herstellung
JPH0510235A (ja) * 1991-07-05 1993-01-19 Nippondenso Co Ltd 内燃機関の点火時期制御装置
WO1995020389A1 (en) * 1994-01-28 1995-08-03 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
US5696133A (en) * 1994-12-22 1997-12-09 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
EP1382597A3 (de) * 1994-12-22 2004-04-07 Ligand Pharmaceuticals, Inc. Steroidrezeptor-Modulator Verbindungen und Methoden
EP0929533B1 (de) * 1996-10-02 2003-09-03 Bristol-Myers Squibb Pharma Company 4,4-disubstituierte 1,4-dihydro-2h-3,1-benzoxazin-2-one die anwendbar sind als hiv-reverstranskriptase-inhibitoren, zwischenprodukte und verfahren zu ihrer herstellung
DE60038108T2 (de) * 1999-05-04 2009-02-12 Wyeth Cyclothiocarbamatderivate als progesteron-rezeptormodulatoren
DE602006013114D1 (de) * 2005-04-28 2010-05-06 Wyeth Corp Mikronisiertes tanaproget und zusammensetzungen damit
HN2006020928A (es) * 2005-06-09 2011-02-16 Wyeth Corp "composiciones de tanaproget que contienen etinil estradiol"

Also Published As

Publication number Publication date
DK1175411T3 (da) 2008-06-09
KR100732692B1 (ko) 2007-06-27
BG106080A (en) 2002-05-31
PL351083A1 (en) 2003-03-10
CA2371712C (en) 2009-12-22
BG65277B1 (bg) 2007-11-30
JP5523430B2 (ja) 2014-06-18
CZ20013952A3 (cs) 2002-05-15
NO20015381L (no) 2002-01-03
AU4811900A (en) 2000-11-17
CN1131856C (zh) 2003-12-24
HUP0203332A2 (hu) 2003-01-28
MXPA01011287A (es) 2003-07-14
BR0010214A (pt) 2002-02-13
CA2371712A1 (en) 2000-11-09
GEP20043181B (en) 2004-02-25
JP2012087129A (ja) 2012-05-10
SG120970A1 (en) 2006-04-26
EP1175411B1 (de) 2008-02-20
NO20015381D0 (no) 2001-11-02
CN1349516A (zh) 2002-05-15
NZ515353A (en) 2004-03-26
JP4958338B2 (ja) 2012-06-20
JP2002543192A (ja) 2002-12-17
NO321370B1 (no) 2006-05-02
EA200101181A1 (ru) 2002-04-25
HUP0203332A3 (en) 2004-12-28
EA004511B1 (ru) 2004-04-29
KR20020000170A (ko) 2002-01-04
AU766801B2 (en) 2003-10-23
DE60038108T2 (de) 2009-02-12
TR200103285T2 (tr) 2002-02-21
EP1175411A1 (de) 2002-01-30
SK15922001A3 (sk) 2002-09-10
ES2301482T3 (es) 2008-07-01
IL146298A0 (en) 2002-07-25
DE60038108D1 (de) 2008-04-03

Similar Documents

Publication Publication Date Title
UA72917C2 (en) Cyclic carbamates derivatives, pharmaceutical composition containing said derivatives of cyclic carbamates and active ingredients as modulators of the progesterone receptor
DE60038108D1 (de) Cyclothiocarbamatderivate als progesteron-rezeptormodulatoren
WO2000066564A8 (en) Benzimidazolones and analogues and their use as progesterone receptor ligands
AR028531A1 (es) Compuestos organicos
HUP0301069A2 (hu) Új biaril-karboxamidok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP0303652A2 (hu) Ciklikus származékok, mint kemokin receptor aktivitás modulátorai és ezeket tartalmazó gyógyszerkészítmények
AR035235A1 (es) Derivados heterocicliloxi-,-tioxi- y -aminobenzazol como ligandos de 5-hidroxitriptamina-6, un procedimiento para su preparacion, composicion farmaceutica, y el uso de dichos derivados para la manufactura de un medicamento
HUP0003073A2 (hu) Benzolszulfonamid-származékok, eljárás előállításukra és gyógyszerként való alkalmazásuk
AR030186A1 (es) Compuesto antibacteriano 3-aminoquinazolina-2,4-diona, composicion farmaceutica que lo comprende y su uso para fabricarla
AR007440A1 (es) Compuestos triciclos fenilamino sustituidos y composiciones farmaceuticas de los mismos.
HUP9801688A2 (hu) Acetamidszármazékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyászati készítmények
BR0014901A (pt) Derivados de trifenil-alquenos e seu uso como moduladores de receptores seletivos de estrogênios
NO994452D0 (no) Substituerte 4-arylmetylen-2-imino-2,3-dihydrotiazoler og derivater, og deres farmasöytiske anvendelse
AR034203A1 (es) Derivados de 1-aril- o 1-alquilsulfonilbenzazol como ligandos de 5-hidroxitriptamina-6, un metodo para su preparacion, composicion farmaceutica y el uso de los mismos para la fabricacion de un medicamento
EE9700227A (et) Arüülglütsiinamiidi derivaadid, meetod nende valmistamiseks ja neid ühendeid sisaldavad farmatseutilised preparaadid
HUP0002272A2 (hu) Piperazinszármazékok, eljárás előállításukra, e vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk
FI952709A (fi) 1,4-bentsodiatsepiinijohdannaisia ja niiden käyttö cck-modulaattoreina
FI894061A (fi) Menetelmä lääkeaineina käyttökelpoisten , -disubstituoitujen N-sykloalkyylialkyylibentsyyliamiinien valmistamiseksi ja niiden synteesivälituotteita
ES2061465T3 (es) Derivados de oxadiazolilalquilpurina, su preparacion y su aplicacion en productos farmaceuticos.
HUP9700595A1 (hu) Fluor-alkil- és fluor-alkoxicsoporttal helyettesített heterociklikus bradikinin-antagonisták, eljárás ezek előállítására, valamint ezek alkalmazása
HUP0301030A2 (hu) Kardiális aritmiák kezelésére alkalmazható új aza-biciklooktán-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
ZA988668B (en) Novel 5-membered ring heterocycles their preparation their use and pharmaceutical preparations comprising them
DE69811556D1 (de) Chinoline und Chinazoline Verbindungen und ihre therapeutische Anwendung
HUP0105407A2 (hu) Triazolo[1,5-a]kinolinszármazékok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények, valamint intermedierek
CO5540322A2 (es) Nuevos derivados heterociclicos que comprenden un anillo de tetrahidroisoquinolina y uso farmaceutico de los mismos

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties